This company listing is no longer active
Abiomed Management
Management criteria checks 3/4
Key information
Mike Minogue
Chief executive officer
US$12.7m
Total compensation
CEO salary percentage | 6.2% |
CEO tenure | 18.7yrs |
CEO ownership | 0.8% |
Management average tenure | 4.5yrs |
Board average tenure | 8.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2022 | n/a | n/a | US$267m |
Jun 30 2022 | n/a | n/a | US$218m |
Mar 31 2022 | US$13m | US$789k | US$137m |
Dec 31 2021 | n/a | n/a | US$133m |
Sep 30 2021 | n/a | n/a | US$149m |
Jun 30 2021 | n/a | n/a | US$154m |
Mar 31 2021 | US$15m | US$608k | US$226m |
Dec 31 2020 | n/a | n/a | US$200m |
Sep 30 2020 | n/a | n/a | US$208m |
Jun 30 2020 | n/a | n/a | US$159m |
Mar 31 2020 | US$17m | US$768k | US$203m |
Dec 31 2019 | n/a | n/a | US$245m |
Sep 30 2019 | n/a | n/a | US$221m |
Jun 30 2019 | n/a | n/a | US$258m |
Mar 31 2019 | US$19m | US$753k | US$259m |
Dec 31 2018 | n/a | n/a | US$222m |
Sep 30 2018 | n/a | n/a | US$190m |
Jun 30 2018 | n/a | n/a | US$165m |
Mar 31 2018 | US$10m | US$718k | US$112m |
Dec 31 2017 | n/a | n/a | US$90m |
Sep 30 2017 | n/a | n/a | US$92m |
Jun 30 2017 | n/a | n/a | US$77m |
Mar 31 2017 | US$12m | US$649k | US$52m |
Dec 31 2016 | n/a | n/a | US$48m |
Sep 30 2016 | n/a | n/a | US$43m |
Jun 30 2016 | n/a | n/a | US$42m |
Mar 31 2016 | US$19m | US$630k | US$38m |
Compensation vs Market: Mike's total compensation ($USD12.67M) is above average for companies of similar size in the German market ($USD4.81M).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
CEO
Mike Minogue (55 yo)
18.7yrs
Tenure
US$12,665,992
Compensation
Mr. Michael R. Minogue, also known as Mike, served as Director at Medical Device Innovation Consortium, previously served as its chairman until June 2019. He has been Chief Executive Officer and President...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 18.7yrs | US$12.67m | 0.77% $ 125.4m | |
Executive VP & CFO | 4.7yrs | US$3.04m | 0.017% $ 2.7m | |
Executive VP | 4.5yrs | US$2.57m | 0.027% $ 4.4m | |
Executive VP & Chief Commercial Officer | 2.7yrs | US$2.84m | 0.045% $ 7.4m | |
Scientific & Technology Advisor | less than a year | US$2.29m | 0.30% $ 49.1m | |
Executive Vice President of Global Operations & Integration | no data | no data | 0.017% $ 2.8m | |
Executive VP & Chief Technology Officer | no data | no data | no data | |
Director of Investor Relations | 8.3yrs | no data | no data | |
Communications Manager | no data | no data | no data | |
VP & GM of Global Sales | 13.8yrs | US$1.71m | no data | |
VP & Chief Human Resources Officer | 3.3yrs | no data | no data | |
Executive VP & Chief Medical Officer | 2.5yrs | no data | no data |
4.5yrs
Average Tenure
55yo
Average Age
Experienced Management: AIO's management team is considered experienced (4.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 18.7yrs | US$12.67m | 0.77% $ 125.4m | |
Independent Director | 14.6yrs | US$266.80k | 0.26% $ 42.6m | |
Independent Director | 6.8yrs | US$266.80k | 0.021% $ 3.3m | |
Independent Director | 11.6yrs | US$269.30k | 0.013% $ 2.0m | |
Independent Director | 8.3yrs | US$259.30k | 0.032% $ 5.2m | |
Independent Lead Director | 19.3yrs | US$299.30k | 0.032% $ 5.1m | |
Independent Director | 1.7yrs | US$499.89k | 0.0011% $ 179.7k | |
Independent Director | 6.8yrs | US$264.30k | 0.015% $ 2.4m | |
Independent Director | 1.8yrs | US$259.30k | 0.0011% $ 184.6k |
8.3yrs
Average Tenure
67yo
Average Age
Experienced Board: AIO's board of directors are considered experienced (8.3 years average tenure).